Hinge Health Inc. Class A Common Stock vs Williams Companies Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Williams Companies Inc trades at $73.41 (market cap $89.05B). The key difference: Williams Companies Inc is far larger — about 10.5× Hinge Health Inc. Class A Common Stock's market cap, and Williams Companies Inc pays a 2.88% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Williams Companies Inc for 58 Days on average.
| HNGE | WMB | |
|---|---|---|
Market Cap | $8.47B | $89.05B |
Volume | 1,624,526 | 10,633,946 |
Sector | Health | Energy |
52-Week High | $105.14 | $79.40 |
52-Week Low | $31.17 | $56.51 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $8.09B | $119.67B |
Dividend Yield | — | 2.88% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
WMB trades at $74.57, up 0.54% with strong bullish technical indicators and analyst consensus. The stock shows robust fundamentals with $11.95B revenue, 25.18% net margin, and consistent dividend payments. Recent earnings beat expectations in Q1 2026, while technical analysis indicates bullish momentum with support at $72-73 and resistance at $75-76 levels.
WMB presents a compelling investment case with strong analyst support (79% buy rating) and $87.08 price target upside. The company benefits from stable fee-based revenues and AI-driven natural gas demand growth. Key risks include energy market volatility and high debt levels, but the resilient midstream model and dividend growth trajectory support long-term value.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →